Evidence map›Paper›PMID 19255154›Full record

ArticleInvestigative ophthalmology & visual science2009

Age-dependent disease expression determines remodeling of the retinal mosaic in carriers of RPGR exon ORF15 mutations.

William A Beltran, Gregory M Acland, Gustavo D Aguirre

Open access · greenAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Retinal degeneration inFrontiers in cell and developmental biology · 2023
    Article
  5. Article
  6. Coming of Age for the Photoreceptor Synapse.Investigative ophthalmology & visual science · 2021
    Article
  7. Candidate Genetic Modifiers for RPGR Retinal Degeneration.Investigative ophthalmology & visual science · 2020
    Article
  8. Dose Range Finding Studies with TwoHuman gene therapy · 2020
    Article
  9. Review
  10. Article
  11. Article
  12. Concepts and Strategies in Retinal Gene Therapy.Investigative ophthalmology & visual science · 2017
    Article
  13. Optimization of Retinal Gene Therapy for X-Linked Retinitis Pigmentosa Due to RPGR Mutations.Molecular therapy : the journal of the American Society of Gene Therapy · 2017
    Article
  14. Article
  15. Genetic rescue models refute nonautonomous rod cell death in retinitis pigmentosa.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  16. Article
  17. Article
  18. The Role of X-Chromosome Inactivation in Retinal Development and Disease.Advances in experimental medicine and biology · 2016
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

William A BeltranSchool of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.wbeltran@vet.upenn.edu
Gregory M Acland
Gustavo D Aguirre
University of Pennsylvania · USCornell University · US

Funding

MODELS OF HEREDITY RETINAL DEGENERATIONR01EY006855 · NEI · UNIVERSITY OF PENNSYLVANIA · PI GUSTAVO David AGUIRRE, William A. Beltran · 1992 to 2026
$20.7M
Scientific TransparencyP30EY001583 · NEI · UNIVERSITY OF PENNSYLVANIA · PI Geoffrey Karl Aguirre · 1985 to 2026
$19.5M
Translational Research for Retinal Degeneration TherapiesR01EY017549 · NEI · UNIVERSITY OF PENNSYLVANIA · PI BELTRAN, WILLIAM A. · 2007 to 2024
$14.1M
SEARCH FOR NOVEL GENES AND MUTATIONS IN THE RP3 INTERVALR01EY013132 · NEI · UNIVERSITY OF PENNSYLVANIA · PI AGUIRRE, GUSTAVO DAVID · 2000 to 2007
$3.2M
NEI NIH HHS EY-06855NEI NIH HHS EY-13132NEI NIH HHS EY-17549NEI NIH HHS P30 EY-001583NEI NIH HHS P30 EY001583NEI NIH HHS R01 EY006855NEI NIH HHS R01 EY013132NEI NIH HHS R01 EY017549
6 · The paper itself

Abstract

purposeTo characterize the retinal histopathology in carriers of X-linked progressive retinal atrophy (XLPRA1 and XLPRA2), two canine models of X-linked retinitis pigmentosa caused, respectively, by a stop and a frameshift mutation in RPGRORF15.

methodsRetinas of XLPRA2 and XLPRA1 carriers of different ages were processed for morphologic evaluation, TUNEL assay, and immunohistochemistry. Cell-specific markers were used to examine retinal remodeling events.

resultsA mosaic pattern composed of patches of diseased and normal retina was first detected in XLPRA2 carriers at 4.9 weeks of age. A peak of photoreceptor cell death led to focal rod loss; however, in these patches an increased density of cones was found to persist over time. Patches of disease gradually disappeared so that by 39 weeks of age the overall retinal morphology, albeit thinner, had improved lamination. In older XLPRA2 carriers (>or=8.8 years), extended regions of severe degeneration occurred in the peripheral/mid-peripheral retina. In XLPRA1 carriers, opsin mislocalization and rare events of rod death were detected by TUNEL assay at 20 weeks of age; however, only patchy degeneration was seen by 1.4 years and was still apparent at 7.8 years.

conclusionsThe time of onset and the progression of the disease differed between the two models. In the early-onset form (XLPRA2) the morphologic appearance of the retinal mosaic changed as a function of age, suggesting that structural plasticity persists in the early postnatal canine retina as mutant photoreceptors die. In the late-onset form (XLPRA1), patches of disease persisted until later ages.

Indexed as

HeterozygoteAgingAnimalsDog DiseasesDogsExonsFemaleFluorescent Antibody Technique, IndirectGenetic Diseases, X-LinkedGuanine Nucleotide Exchange FactorsIn Situ Nick-End LabelingMaleMutationOpen Reading FramesPhotoreceptor Cells, VertebrateRetinitis PigmentosaGuanine Nucleotide Exchange Factors

Identifiers

PMID19255154
PMCPMC2718058
OpenAlexW1976894277

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.